Photo from wikipedia
Beta2‐microglobulin, a novel marker of kidney function, predicts kidney failure and mortality in the general population. However, few studies have evaluated the association of serum β2‐MG level with clinical outcome… Click to show full abstract
Beta2‐microglobulin, a novel marker of kidney function, predicts kidney failure and mortality in the general population. However, few studies have evaluated the association of serum β2‐MG level with clinical outcome in maintenance hemodialysis (MHD) patients.
Keywords:
high serum;
mortality;
microglobulin;
maintenance hemodialysis
Journal Title: Seminars in Dialysis
Year Published: 2022
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Seminars in Dialysis
Year Published: 2022
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!